Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …

Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population
worldwide. The characteristic white patches result from the selective loss of melanocytes …

British Association of Dermatologists guidelines for the management of people with vitiligo 2021*
| British Journal of Dermatology | Oxford Academic Skip to Main Content Advertisement intended …

Importance Previous studies found conflicting results as to whether atopic dermatitis (AD) is
increased in patients with vitiligo and alopecia areata (AA). Objective To compare the …

Pigmentation disorders include a large number of heterogeneous conditions that are usually
characterized by altered melanocyte density, melanin concentration, or both, and result in …

Background Thyroid disease has been suggested to be associated with vitiligo. However,
the outcomes of prevalence studies on thyroid disease in vitiligo vary widely. Objectives To …

Vitiligo is a chronic, acquired depigmenting condition of the skin, and sometimes of the
mucosa, that results in the selective loss of melanocytes. 1 Vitiligo has been reported since …

Background Fufang Honghua Buji (FHB) granules, have proven efficacy against vitiligo in
long-term clinical practice. However, its major active chemical components and molecular …

Vitiligo is a T-cell mediated skin disorder characterized by progressive loss of skin color. In
individuals genetically predisposed to the disease, various triggers contribute to the initiation …

Vitiligo is a common depigmentation disorder of an unknown origin characterized by the
selective loss of melanocytes, resulting in typical white macules and patches. However …